Content includes cutting edge research, updates from collaborating networks, and physician education.
Dr. Rachna Shroff, Division Chief of Hematology/Oncology and Associate Dean of Clinical & Translational Research at the University of Arizona discuss the latest updates in the treatment of GI cancers highlighted at ESMO with OncBrothers in our latest installment.
OncBrothers are back with the latest installment! Dr. Toni Choueiri, Director @ Lank Center for Genitourinary Oncology and Professor of Medicine at Harvard Medical School discuss the latest updates in the treatment of GU cancers highlighted at ESMO.
This installment has been contributed by OncBrothers. Drs. Rohit Gosain, M.D. and Rahul Gosain, M.D. are practicing medical oncologists and hematologists offering their perspectives as community leaders. They both have excelled in their respective fields, gaining outstanding achievement awards in their top educational institutions and medical residencies. Their goal is to bridge the gap between academia and community oncology by educating their peers and providing appropriate standard of care treatment for all their patients in the community. Featuring Sara Tolaney, M.D., Chief, Division of Breast Oncology, Dana-Farber
This installment has been contributed by OncBrothers. Drs. Rohit Gosain, M.D. and Rahul Gosain, M.D. are practicing medical oncologists and hematologists offering their perspectives as community leaders. They both have excelled in their respective fields, gaining outstanding achievement awards in their top educational institutions and medical residencies. Their goal is to bridge the gap between academia and community oncology by educating their peers and providing appropriate standard of care treatment for all their patients in the community.
This installment has been contributed by OncBrothers. Drs. Rohit Gosain, M.D. and Rahul Gosain, M.D. are practicing medical oncologists and hematologists offering their perspectives as community leaders. They both have excelled in their respective fields, gaining outstanding achievement awards in their top educational institutions and medical residencies. Their goal is to bridge the gap between academia and community oncology by educating their peers and providing appropriate standard of care treatment for all their patients in the community.
This installment has been contributed by OncBrothers. Drs. Rohit Gosain, M.D. and Rahul Gosain, M.D. are practicing medical oncologists and hematologists offering their perspectives as community leaders. They both have excelled in their respective fields, gaining outstanding achievement awards in their top educational institutions and medical residencies. Their goal is to bridge the gap between academia and community oncology by educating their peers and providing appropriate standard of care treatment for all their patients in the community.
Dr. Yan Leyfman presents recent finding regarding cancer and COVID-19, along with insights on how patients may be treated for long COVID. Hosted by Dr. Chandler Park.
Presented by Dr. Maxwell Krem
Dr. Jaspreet Grewal with the Norton Cancer Institute in Louisville, Kentucky covers a new treatment indication for patients with Gastric, Gastroesophageal Junction and Esophageal Carcinoma.
Dr. Maxwell Krem reviews a study conducted at UK. They looked at 146 episodes of COVID 19 infections in patients to assess what might predict how the patient would do and overall outcomes. Populations assessed included minorities, elderly or patients with certain cancer types. They also examined the effect of COVID on rural cancer populations and other areas of socioeconomic studies.
Dr. Reema Patel, medical oncologist at the University of Kentucky Markey Cancer Center discusses recent NEJM article regarding the use of adjuvant Nivolumab in Esophageal Cancer and possible implications for future research.
© 2020-2025 Ivy Podcast Discovery LLC
